1. Home
  2. UONE vs LPCN Comparison

UONE vs LPCN Comparison

Compare UONE & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban One Inc.

UONE

Urban One Inc.

N/A

Current Price

$4.06

Market Cap

23.3M

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$1.58

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UONE
LPCN
Founded
1980
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
18.7M
IPO Year
1999
2011

Fundamental Metrics

Financial Performance
Metric
UONE
LPCN
Price
$4.06
$1.58
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
7.8K
★ 347.1K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $439,098,000.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.86
$1.36
52 Week High
$16.94
$12.37

Technical Indicators

Market Signals
Indicator
UONE
LPCN
Relative Strength Index (RSI) 44.72 47.28
Support Level $3.95 N/A
Resistance Level $4.33 $2.50
Average True Range (ATR) 0.20 0.10
MACD 0.02 0.03
Stochastic Oscillator 26.98 85.00

Price Performance

Historical Comparison
UONE
LPCN

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: